Trial intelligence / Profile preview

DEB vs POBA for failing dialysis access

NCT05173857Completed

Sponsor
Skåne University Hospital
Start
Mar 2014
Primary completion
Jul 2017
Modality
Small Molecules
01

Overview

Randomised, open-label trial of paclitaxel in arteriovenous fistula stenosis and arteriovenous graft stenosis (2 arms), sponsored by Skåne University Hospital. Primary endpoints: Freedom from restenosis in treated vascular access at 12 months, Stenosis or occlusion in treated vascular access at 12 months and 1 more. Started Mar 2014; status: completed.

02

Drugs

paclitaxel
03

Conditions

arteriovenous fistula stenosisarteriovenous graft stenosis

Beyond the preview

Go deeper on NCT05173857.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05173857.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call